Stay updated on Remibrutinib Long-term Extension in Urticaria Clinical Trial
Sign up to get notified when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.

Latest updates to the Remibrutinib Long-term Extension in Urticaria Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.5.0 has been added and v3.4.3 has been removed.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded new study locations across multiple countries (examples include Uskudar, Melikgazi, Karsiyaka, Karabaglar, Efeler, Buca, Atakum, Adapazari, Hajdu Bihar Megye, Hesse, Bavaria, Cundinamarca, and more) and removed numerous sites; total locations updated from 207 to 208.SummaryDifference2%

- Check53 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2, indicating a minor UI/version change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision label updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.0%

- Check68 days agoChange DetectedNew UI elements include a glossary toggle and a revision label (Revision: v3.4.0); existing QC-related labels were adjusted only in capitalization (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision metadata updated to v3.3.4, replacing the previous v3.3.3. This appears to be a minor, non-content change to the page.SummaryDifference0.0%

Stay in the know with updates to Remibrutinib Long-term Extension in Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remibrutinib Long-term Extension in Urticaria Clinical Trial page.